Shelby Derene Reed, PhD

Professor in Population Health Sciences
Professor in Medicine
Associate of the Duke Initiative for Science & Society
Executive Core Faculty Member, Duke-Margolis Center for Health Policy
Member in the Duke Clinical Research Institute
Member of the Duke Cancer Institute
Campus mail 300 N Mangum Street, Durham, NC 27701
Phone (919) 668-8991
Email address shelby.reed@duke.edu

Shelby D. Reed, PhD, is Professor in the Departments of Population Health Sciences and Medicine at Duke University’s School of Medicine.  She is the director of the Center for Informing Health Decisions and Therapeutic Area leader for Population Health Sciences at the Duke Clinical Research Institute (DCRI).  She also is core faculty at the Duke-Margolis Center for Health Policy. Dr. Reed has over 20 years of experience leading multidisciplinary health outcomes research studies. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of diagnostics, drugs and patient-centered interventions. In 2016, she co-founded the Preference Evaluation Research (PrefER) Group at the DCRI, and she currently serves as its director. She and the group are frequently sought to conduct stated-preference studies to inform regulatory decisions, health policy, care delivery, value assessment and clinical decision making with applied projects spanning a wide range of therapeutic areas. She served as President for ISPOR in 2017-2018, and she currently is Past-Chair of the Society’s Health Science Policy Council.

 

 

Areas of expertise: Health Economics, Health Measurement, Stated Preference Research, Health Policy, and Health Services Research

Education and Training

  • Ph.D., University of Maryland, College Park, 1998

Publications

Dong, Olivia M., Pradeep J. Poonnen, David Winski, Shelby D. Reed, Vishal Vashistha, Jill Bates, Michael J. Kelley, and Deepak Voora. “Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma.” Value Health 25, no. 4 (April 2022): 582–94. https://doi.org/10.1016/j.jval.2021.09.017.

PMID
35365302
Full Text

Hung, Anna, Yanhong Li, Danielle Candelieri, Patrick Alba, Tori Anglin-Foote, Kyung Min Lee, Fatai Agiri, et al. “Factors associated with gene mutation testing in United States veterans with metastatic castration-resistant prostate cancer.” In Journal of Clinical Oncology, 40:47–47. American Society of Clinical Oncology (ASCO), 2022. https://doi.org/10.1200/jco.2022.40.6_suppl.047.

Full Text

Chew, Derek S., Yanhong Li, Michel Zeitouni, David J. Whellan, Dalane Kitzman, Robert J. Mentz, Pamela Duncan, et al. “Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.” Jama Cardiol 7, no. 2 (February 1, 2022): 140–48. https://doi.org/10.1001/jamacardio.2021.4836.

PMID
34817542
Full Text

Sinha, Saurabh R., Jui-Chen Yang, Matthew J. Wallace, Kiran Grover, F Reed Johnson, and Shelby D. Reed. “Patient preferences pertaining to treatment options for drug-resistant focal epilepsy.” Epilepsy Behav 127 (February 2022): 108529. https://doi.org/10.1016/j.yebeh.2021.108529.

PMID
35016055
Full Text

Becker, Frauke, Helen A. Dakin, Shelby D. Reed, Yanhong Li, José Leal, Stephanie M. Gustavson, Eric Wittbrodt, Adrian F. Hernandez, Alastair M. Gray, and Rury R. Holman. “Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial.” Diabetes Res Clin Pract 183 (January 2022): 109152. https://doi.org/10.1016/j.diabres.2021.109152.

PMID
34813910
Full Text

Reed, Shelby D., Jui-Chen Yang, Timothy Rickert, F Reed Johnson, Juan Marcos Gonzalez, Robert J. Mentz, Mitchell W. Krucoff, et al. “Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study.” Circ Heart Fail 15, no. 1 (January 2022): e008797. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008797.

PMID
34937393
Full Text

Whellan, David J., Dalane W. Kitzman, Haiying Chen, Michael B. Nelson, Amy M. Pastva, Melissa McCarey, Pamela W. Duncan, Robert J. Mentz, and Shelby D. Reed. “Characterizing Changes in Quality of Life and in Older Patients With Acute Decompensated Heart Failure Enrolled in a Rehab Intervention Clinical Trial.” In Circulation, Vol. 144, 2021.

Scholars@Duke

Maxfield, Charles M., J Felipe Montano-Campos, Teresa Chapman, Terry S. Desser, Christopher P. Ho, Nathan C. Hull, Hillary R. Kelly, et al. “Factors Influential in the Selection of Radiology Residents in the Post-Step 1 World: A Discrete Choice Experiment.” J Am Coll Radiol 18, no. 11 (November 2021): 1572–80. https://doi.org/10.1016/j.jacr.2021.07.005.

PMID
34332914
Full Text

Gonzalez, J. M., S. D. Reed, and F. R. Johnson. “Stratified psoriasis treatment plans: why is patient preference information needed?” Br J Dermatol 185, no. 5 (November 2021): 882–83. https://doi.org/10.1111/bjd.20697.

PMID
34463961
Full Text

Sepulveda, Juan Marcos Gonzalez, Jui-Chen Yang, Shelby D. Reed, Ting-Hsuan Lee, Sarah Stothers, Kaiwen Li, Xinyi Ng, Martin Ho, and Telba Irony. “Health Baselines and Stated Preferences: Quantifying the Evolution of Preferences Using LCA.” In Patient Patient Centered Outcomes Research, 14:867–68, 2021.

Scholars@Duke

Pages